Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
NC elections upended by Helene: Voting could be delayed, ballots might be lost. Here's what you need to know
Recommended
Homeowners insurance doesn't cover floods: How to protect your home in North Carolina
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Willow Biosciencesinc
(TSX:
WLLW
)
0.1050
UNCHANGED
Streaming Delayed Price
Updated: 3:57 PM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.1050
Bid (Size)
0.1000 (80)
Ask (Size)
0.1050 (265)
Prev. Close
0.1050
Today's Range
0.1050 - 0.1050
52wk Range
0.0650 - 0.1500
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
CBG Producer Willow Biosciences Reports Record Q2 Revenue, Enters Major Pharma Deal Slated To Be Key Driver Of Growth
August 12, 2024
Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) reported on Monday its financial and operating results for the three months ended June 30, 2024, reporting significantly higher revenue and reduced...
Via
Benzinga
Company Exploring CBG Production Signals New Era Of Commercial Success In Synthetic Biology
January 10, 2024
Biotechnology company Willow Biosciences generated around $1.3m in revenues in 2023, a 60% increase from the previous year. The company has hailed 2023 as a "transformative year," citing the launch of...
Via
Benzinga
Performance
YTD
+5.00%
+5.00%
1 Month
+10.53%
+10.53%
3 Month
-8.70%
-8.70%
6 Month
+10.53%
+10.53%
1 Year
+23.53%
+23.53%
More News
Read More
This Precision-Fermentation Company Achieves Q3 Record Revenue And Strategic Milestones In Business Expansion
November 15, 2023
Via
Benzinga
Willow Biosciences Touts Strong Q3 Results, Continues Its Focus On Biosynthetically Produced Cannabinoids
November 15, 2021
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.